The dilemma in pausing J & J vaccine over risk of blood clots: Will it save lives or cost them?
A CDC advisory panel is grappling with the best way to "do no harm" regarding Johnson & Johnson's COVID-19 vaccine and its risk of blood clots.
Source: L.A. Times - Health - Category: Consumer Health News Authors: Melissa Healy Source Type: news